Global Health Limited Stock Price Today (NSE: MEDANTA)
Fundamental Score
Global Health Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Global Health Limited share price today is ₹1458.10, down 1.46% on NSE/BSE as of 1 September 2026. Global Health Limited (MEDANTA) is a Large-cap company in the Hospital sector with a market capitalisation of ₹35.99K (Cr). The 52-week high for MEDANTA share price is ₹1544.00 and the 52-week low is ₹956.00. At a P/E ratio of 64.72x, MEDANTA is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 15.15% and a debt-to-equity ratio of 0.30.
Global Health Limited Share Price Chart — NSE/BSE Historical Performance
Global Health Limited share price chart: 8.36% return over the past month. 52-week high ₹1544.00, 52-week low ₹956.00.
Global Health Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1480.90 | ₹1500.10 | ₹1448.20 | ₹1458.10 | 2.56L (Cr) | |
| ₹1465.00 | ₹1490.40 | ₹1456.80 | ₹1479.70 | 2.46L (Cr) | |
| ₹1520.50 | ₹1531.40 | ₹1462.10 | ₹1472.20 | 4.04L (Cr) | |
| ₹1466.20 | ₹1544.00 | ₹1455.20 | ₹1508.90 | 11.10L (Cr) | |
| ₹1410.00 | ₹1476.00 | ₹1410.00 | ₹1458.90 | 6.07L (Cr) | |
| ₹1402.00 | ₹1414.00 | ₹1393.00 | ₹1404.40 | 69.43K (Cr) | |
| ₹1400.10 | ₹1411.10 | ₹1395.70 | ₹1405.50 | 92.48K (Cr) | |
| ₹1408.20 | ₹1414.70 | ₹1401.00 | ₹1409.70 | 1.18L (Cr) | |
| ₹1420.00 | ₹1429.60 | ₹1401.00 | ₹1408.20 | 1.21L (Cr) | |
| ₹1442.90 | ₹1445.00 | ₹1412.00 | ₹1417.20 | 80.45K (Cr) |
Global Health Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1480.90 | ₹1500.10 | ₹1448.20 | ₹1458.10 | -1.54% | |
| ₹1412.60 | ₹1544.00 | ₹1380.00 | ₹1479.70 | +4.75% | |
| ₹1320.70 | ₹1438.00 | ₹1295.90 | ₹1405.60 | +6.43% | |
| ₹1199.90 | ₹1335.90 | ₹1153.00 | ₹1313.80 | +9.49% | |
| ₹1116.20 | ₹1278.00 | ₹1112.10 | ₹1189.00 | +6.52% | |
| ₹976.15 | ₹1179.00 | ₹959.65 | ₹1117.25 | +14.45% | |
| ₹1100.00 | ₹1134.40 | ₹956.00 | ₹961.10 | -12.63% | |
| ₹1115.00 | ₹1189.70 | ₹1050.10 | ₹1138.80 | +2.13% | |
| ₹1186.30 | ₹1244.00 | ₹1013.40 | ₹1053.80 | -11.17% | |
| ₹1252.20 | ₹1258.00 | ₹1115.00 | ₹1186.40 | -5.25% | |
| ₹1313.00 | ₹1318.40 | ₹1146.20 | ₹1246.00 | -5.10% | |
| ₹1310.40 | ₹1414.70 | ₹1293.20 | ₹1311.50 | +0.08% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Overvalued hospital chain relying on premium pricing in an increasingly competitive market; hold, but watch closely.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Global Health filed its Q4 FY26 compliance certificate on April 2, 2026. A domestic brokerage maintained a 'Buy' rating on the stock and set a target price of Rs 1,382 on March 25, 2026.
CORE STORY (THE REAL GAME)
Medanta is a bet on the continued expansion of private healthcare in India, specifically its ability to capture high-margin quaternary care demand in the North and East. It's a play on rising incomes and willingness to pay for premium healthcare, not a generic hospital roll-up story.
- Brokerage reiterating 'Buy' rating provides short-term support
- Improving occupancy rates signal operational efficiency
- Strong brand recognition in quaternary care
- Faster-than-expected ramp-up of Noida facility
- Acquisition of smaller regional players
- Government policies favoring private healthcare
- High P/E ratio relative to industry peers
- Noida facility could dilute earnings
- Micro/SME cap — liquidity risk
DII increased holdings by 0.77%, while FII decreased by 0.13%.
Healthcare spending in India is increasing, but rising input costs due to geopolitical tensions pose a threat.
Yes - Free Cash Flow 5Y: ₹992.45 Cr
Medanta needs to demonstrate consistent profitability from its new facilities to justify its valuation. Watch for occupancy rates and average revenue per patient.
Primary Thesis Risk
Overvaluation leaves no margin for error in execution or external shocks.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Global Health Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Global Health Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDANTA across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (15.15%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (16.85%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (23.82%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Revenue Growth (26.50%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Interest Coverage (10.04x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 2.67)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹630.86 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 64.72x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Price-to-Book Ratio (9.09x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Global Health Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Global Health Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Global Health LimitedGlobal Health L...Selected✓ MEDANTA • 543654 | 59.9/100 | ₹1458.10₹1458 | ₹35993.93₹35993.93 | 64.72Average 64.7 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | — — | — — | 0.04% |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 62.1/100 | ₹8817.00₹8817 | ₹128448.55₹128448.55 | 61.47Average 61.5 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 56.9/100 | ₹1014.40₹1014 | ₹107422.79₹107422.79 | 73.71Average 73.7 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | — — | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 56.8/100 | ₹916.70₹917 | ₹73687.64₹73687.64 | 70.32Average 70.3 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | — — | 17.76%Excellent 17.76% Excellent | 0.10% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 37.2/100 | ₹818.00₹818 | ₹71917.90₹71917.90 | 225.67Average 225.7 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 68.3/100 | ₹1803.00₹1803 | ₹41592.95₹41592.95 | 50.96Average 51.0 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | — — | 25.05%Excellent 25.05% Excellent | 0.22% |
13.9/100 | ₹805.50₹806 | ₹33947.05₹33947.05 | 166.00Average 166.0 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 48.5/100 | ₹502.60₹503 | ₹15618.15₹15618.15 | 105.26Average 105.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | — — | — — | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 65.5/100 | ₹1458.70₹1459 | ₹15270.28₹15270.28 | 53.51Average 53.5 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | — — | — — | 0.23% |
60/100 | ₹318.20₹318 | ₹9829.95₹9829.95 | 52.28Average 52.3 Average | 13.41%Average 13.41% Average | 15.25%Good 15.25% Good | 0.33Excellent 0.3 Excellent | — — | — — | 0.07% | |
42.7/100 | ₹713.65₹714 | ₹9663.25₹9663.25 | 424.20Average 424.2 Average | 1.22%Poor 1.22% Poor | 7.43%Poor 7.43% Poor | 0.68Good 0.7 Good | — — | 20.22%Excellent 20.22% Excellent | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price128448.55 Cr
- Max Healthcare Institute Limited share price107422.79 Cr
- Fortis Healthcare Limited share price73687.64 Cr
- Aster DM Quality Care Limited share price71917.90 Cr
- Narayana Hrudayalaya Ltd. share price41592.95 Cr
Global Health Limited PE Ratio History
Historical price-to-earnings ratio for MEDANTA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹17.92 | ₹1186.40 | 66.2x |
| FY 2024 | ₹17.80 | ₹1078.50 | 60.6x |
| FY 2023 | ₹12.57 | ₹959.15 | 76.3x |
| FY 2022 | ₹7.73 | ₹468.80 | 60.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Global Health Limited Quarterly Performance
Latest quarterly metrics for MEDANTA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
26.50%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-0.18%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Global Health Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MEDANTA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Global Health Limited Financial Statements
Annual income statement, balance sheet and cash flow for Global Health Limited (MEDANTA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Global Health Limited
About MEDANTA (Global Health Limited)
Global Health Ltd is a beacon of hope and healing, a sprawling medical sanctuary where cutting-edge technology meets compassionate care. Imagine stepping into a space where gleamin...g corridors intersect with tranquil gardens, and the air hums with the quiet dedication of world-class specialists. This is not just a hospital; it's a meticulously designed ecosystem focused on restoring well-being, a haven where complex medical challenges are met with unwavering expertise and a holistic approach to patient recovery. From the inviting reception areas bathed in natural light to the advanced diagnostic suites buzzing with innovation, every detail is crafted to create an environment of trust, comfort, and unwavering confidence in the journey towards improved health. The heart of Global Health Ltd lies in its multidisciplinary teams, a collaborative force of surgeons, physicians, nurses, and therapists working in perfect synchronicity. Picture a network of interconnected centers of excellence, each dedicated to a specific field, yet seamlessly integrated to offer comprehensive care. Here, breakthroughs in minimally invasive surgery walk hand-in-hand with personalized rehabilitation programs. Imagine advanced oncology treatments delivered with personalized care, neurosurgical precision honed through years of experience, and life-saving transplants performed with unmatched skill. It's a place where innovation transcends textbook medicine, where individual patient needs are met with a level of detailed attention that elevates healthcare to an art form. Beyond the advanced technology and clinical expertise, Global Health Ltd is defined by its culture of empathy and patient-centricity. Visualize dedicated support staff guiding patients and families through every step of their medical journey, offering comfort, clarity, and unwavering encouragement. From personalized dietary plans crafted by expert nutritionists to calming therapies designed to ease anxiety, every aspect of the experience is designed to foster a sense of well-being and empowerment. It's a place where healing extends beyond the physical, addressing the emotional and psychological needs of each patient, creating a true partnership between caregivers and those entrusted to their care.
Company Details
Key Leadership
Corporate Events
Latest News
MEDANTA Share Price: Frequently Asked Questions
What is the current share price of Global Health Limited?
Global Health Limited (MEDANTA) trades at ₹1458.10 on NSE and BSE. Market cap ₹35.99K (Cr). Educational data only.
What is the P/E ratio of Global Health Limited?
Global Health Limited has a P/E of 64.72x vs industry average 48.79x.
What is the Bull Run score for Global Health Limited?
Global Health Limited has a Bull Run score of 59.9/100 based on 25+ financial parameters.
Does Global Health Limited pay dividends?
Global Health Limited has a dividend yield of 0.04%. Past dividends don't guarantee future payments.
What is the ROE of Global Health Limited?
Global Health Limited has ROE of 15.15%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Global Health Limited?
Global Health Limited has debt-to-equity of 0.30.
Is Global Health Limited a good investment?
Bull Run gives Global Health Limited a score of 59.9/100. This is not investment advice — consult a SEBI-registered advisor.